Missense mutation affecting human inherited arrhythmogenic disease auxiliary diagnosis and clinical intervention and application of missense mutation
A technology for arrhythmia and missense mutations, applied in the field of missense mutations, can solve problems that have not been used as targets for the prevention and treatment of arrhythmias, and achieve the effect of preventing the spread of arrhythmias, good application prospects, and reliable specificity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0038] Example 1 Disease correlation of mutation sites
[0039] 1. DNA extraction and whole exome sequencing
[0040] Take 200 microliters of whole blood samples, use the extraction method to extract the whole genome DNA, and use Nanodrop2000 to detect the quality and concentration of DNA. The ratio of A260 / 280 is 1.8-2.0, and the ratio of A260 / 230 wallpaper is 1.7-1.9. Finally, the qualified DNA samples were uniformly diluted to 100 ng / μl. Perform high-throughput sequencing on qualified DNA samples to obtain relevant gene mutation information.
[0041] 2. ACMG genetic variation classification analysis:
[0042]The mutation was a de novo mutation in the subject, and no family history (PS2) was verified by both parents. The variant is located in the calcium binding critical domain (PM1) of the encoded protein. This variation has not been reported in the literature and has not been included in known reference databases. This variation does not belong to polymorphic changes ...
Embodiment 2
[0045] Example 2 Detection method of mutation site
[0046] 1. Amplification of a target fragment containing a missense mutation site in a gene significantly associated with the onset of human arrhythmia.
[0047] The target fragment is a 784bp nucleotide sequence on the third exon of the CALM2 gene, and the upstream and downstream primers for sequence amplification are:
[0048] The upstream primer PCR-F is: 5'-GTGACAGAGGAGCCAGTCATTT-3' (SEQ ID NO.2)
[0049] The downstream primer PCR-R is: 5'-TTTAACATATCCAGTCCTTGACGTA-3' (SEQ ID NO.3)
[0050] Concentration: 100μmol / L
[0051] 2) System preparation:
[0052]
[0053] 3) Reaction procedure:
[0054]
[0055] 3. DNA sequence sequencing identification: sequence sequencing was performed on 3730xlDNAAnalyzer (ABI Company). The measured sequence was compared with the NCBI genome sequence to obtain the genotype corresponding to the single nucleotide site. The sequencing results are as follows:
[0056] GTGACAGAGGAGCCAG...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com